ATE160573T1 - 1,3.5 (10) - estratriene derivate mit oraler wirkung - Google Patents

1,3.5 (10) - estratriene derivate mit oraler wirkung

Info

Publication number
ATE160573T1
ATE160573T1 AT94928126T AT94928126T ATE160573T1 AT E160573 T1 ATE160573 T1 AT E160573T1 AT 94928126 T AT94928126 T AT 94928126T AT 94928126 T AT94928126 T AT 94928126T AT E160573 T1 ATE160573 T1 AT E160573T1
Authority
AT
Austria
Prior art keywords
estratrienic
derivatives
beta
oral action
oral
Prior art date
Application number
AT94928126T
Other languages
English (en)
Inventor
Hyun K Kim
Richard P Blye
Gabriel Bialy
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of ATE160573T1 publication Critical patent/ATE160573T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AT94928126T 1993-09-17 1994-09-15 1,3.5 (10) - estratriene derivate mit oraler wirkung ATE160573T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/122,853 US5554603A (en) 1993-09-17 1993-09-17 Orally active derivatives of 1,3,5(10)-estratriene

Publications (1)

Publication Number Publication Date
ATE160573T1 true ATE160573T1 (de) 1997-12-15

Family

ID=22405185

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94928126T ATE160573T1 (de) 1993-09-17 1994-09-15 1,3.5 (10) - estratriene derivate mit oraler wirkung

Country Status (11)

Country Link
US (1) US5554603A (de)
EP (1) EP0719276B1 (de)
JP (1) JP3993228B2 (de)
AT (1) ATE160573T1 (de)
AU (1) AU700576B2 (de)
CA (1) CA2171740C (de)
DE (1) DE69407057T2 (de)
DK (1) DK0719276T3 (de)
ES (1) ES2110258T3 (de)
GR (1) GR3025872T3 (de)
WO (1) WO1995007925A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054446A (en) * 1997-12-24 2000-04-25 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
US6503896B1 (en) 1997-12-24 2003-01-07 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
US6548491B2 (en) * 1997-12-24 2003-04-15 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
DE19906159A1 (de) * 1999-02-09 2000-08-10 Schering Ag 16-Hydroxyestratriene als selektiv wirksame Estrogene
WO2004098538A2 (en) * 2003-03-13 2004-11-18 Nitromed, Inc. Nitrosated and nitrosylated compounds, compositions and methods of use
US7304171B2 (en) * 2004-05-27 2007-12-04 Migenix Corp. Compounds and methods for cytoprotection
EP2265629B1 (de) * 2008-03-05 2015-06-24 Evestra, Inc. Bismethylen-17-carbolactone und damit in zusammenhang stehende anwendungen
CA2725578A1 (en) * 2008-04-24 2009-10-29 Evestra, Inc. Oral contraceptive dosage forms comprising a progestogen dispersed in an enteric polymer and further comprising an estrogen
EP2367808A4 (de) * 2008-11-25 2012-05-09 Evestra Inc PROGESTATIVE 3-(6,6-ETHYLEN-17b-HYDROXY-3-OXO-17a-PREGNA-4-EN-17a-YL) PROPIONSÄURE-g-LACTONE
CA2798034A1 (en) * 2010-03-28 2011-10-13 Evestra, Inc. Intravaginal drug delivery device

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1074493A (en) * 1963-06-12 1967-07-05 Roussel Uclaf Novel estrane derivatives and processes for preparing them
FR5241M (de) * 1966-02-24 1967-07-17
NL135316C (de) * 1966-11-18
GB1332784A (en) * 1969-11-21 1973-10-03 Glaxo Lab Ltd Nitrates of steroid 11 beta-ols
US3980681A (en) * 1969-11-21 1976-09-14 Peter Job Sykes Process for the preparation of 11-β-nitro-oxysteroids
US4705783A (en) * 1985-06-25 1987-11-10 Sri International 9α, 11β-substituted and 11β-substituted estranes

Also Published As

Publication number Publication date
AU7728494A (en) 1995-04-03
US5554603A (en) 1996-09-10
DE69407057T2 (de) 1998-04-09
CA2171740C (en) 2005-07-26
ES2110258T3 (es) 1998-02-01
DE69407057D1 (de) 1998-01-08
JP3993228B2 (ja) 2007-10-17
EP0719276B1 (de) 1997-11-26
AU700576B2 (en) 1999-01-07
JPH09505802A (ja) 1997-06-10
DK0719276T3 (da) 1998-08-10
CA2171740A1 (en) 1995-03-23
EP0719276A1 (de) 1996-07-03
WO1995007925A1 (en) 1995-03-23
GR3025872T3 (en) 1998-04-30

Similar Documents

Publication Publication Date Title
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
NL300017I1 (nl) Gesubstitueerde androsta-1,4-dieen-3,17-dionen, alsmede farmaceutische preparaten die dergelijke verbindingen bevatten.
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
BG99261A (en) Steroid glycosides for the treatment of hyperchlesterolemia
NO965516D0 (no) Sterolderivater anvendt til regulering av meiose
UA43378C2 (uk) Композиція для лікування респіраторного дистрес-синдрому новонароджених та респіраторного дистрес-синдрому дорослих
FI925615A0 (fi) Stabiliserade farmaceutiska kompositioner, som innehaoller en hmg-coa-reduktas-inhibitorfoerening
OA09458A (en) Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof.
LU90366I2 (fr) Nasonex
DK0608912T3 (da) Synergistiske mikrobicide sammensætninger
DE69300694D1 (de) Desinfizierende Zusammensetzungen.
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
EP0247167A4 (de) Hydroxy- und aminothiazolyl-benzodiazinonverbindungen, kardiotonische mittel, die diese enthalten und verwendungen.
GR1000118B (el) Συνθεσις 1,2-διοξετανων & ενδιαμεσαι ουσιαι δι αυτην.
MX9601994A (es) Profarmacos de derivados de paclitaxel.
AU2732597A (en) Novel pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
SE9604348D0 (sv) Användning av hydroxyguanidiner
ATE160573T1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
EP0136569A3 (de) Isoflavon-Derivate, ihre Herstellung und Verwendung
MX9200748A (es) Formulaciones de esteroides. formulaciones de esteroides.
ZA973289B (en) Steroids, their use as medicaments, their preparation process, the intermediates of this process and the compositions containing them.
DE69431662D1 (de) Stabilisierte tablettenformulierung
ZA929879B (en) Compositions for the treatment of mammalian diseases.
FI923751A0 (fi) Hexahydrobenso/f/kinolinoner.
ATE204286T1 (de) Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee